Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹890 Cr
up ₹57.8 Cr vs Sep 2020
- Stocks held
- 24
- unchanged
- Top 10 weight
- 58.1%
- of the portfolio in its ten largest
- Cash & debt
- 8.2%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 9
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In October 2020 it disclosed 24 stocks worth ₹890 Cr, up ₹57.8 Cr from Sep 2020. Its largest positions were IPCA Laboratories Limited (9.7%), Cipla Limited (9.5%), Dr. Reddy's Laboratories Limited (9.2%); the ten largest together made up 58.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 63.5% of its equity. Cash and debt stood at 8.2%. Compared with Sep 2020 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
79%
Top-10 weight is higher than 79% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
88%
Holds more cash than 88% of peers
What these mean: concentration · cash
Holdings in October 2020
Download CSVEvery line the fund disclosed, with the change against Sep 2020. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| IPCA Laboratories Limited | 9.68% | up 1.83 pts | ₹86.2 Cr | up ₹20.8 Cr | Added |
| Cipla Limited | 9.46% | down 0.12 pts | ₹84.2 Cr | up ₹4.4 Cr | Added |
| Dr. Reddy's Laboratories Limited | 9.19% | up 0.10 pts | ₹81.9 Cr | up ₹6.2 Cr | Added |
| Cash, TREPS & receivables | 8.18% | up 1.63 pts | ₹72.8 Cr | up ₹18.3 Cr | Added |
| Divi's Laboratories Limited | 5.93% | up 0.30 pts | ₹52.8 Cr | up ₹5.9 Cr | Added |
| Apollo Hospitals Enterprise Limited | 5.01% | down 0.42 pts | ₹44.6 Cr | down ₹60 L | Trimmed |
| Procter & Gamble Health Limited | 4.22% | down 0.17 pts | ₹37.6 Cr | up ₹1 Cr | Added |
| Torrent Pharmaceuticals Limited | 4.09% | down 0.68 pts | ₹36.4 Cr | down ₹3.3 Cr | Trimmed |
| JB Chemicals & Pharmaceuticals Limited | 3.74% | down 0.25 pts | ₹33.3 Cr | up ₹6 L | Held |
| Intuitive Surgical Inc | 3.47% | up 0.24 pts | ₹30.9 Cr | up ₹4 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 3.35% | down 0.42 pts | ₹29.8 Cr | down ₹1.5 Cr | Trimmed |
| Dr. Lal Path Labs Limited | 3.33% | up 0.42 pts | ₹29.7 Cr | up ₹5.4 Cr | Added |
| Max Healthcare Institute Limited | 3.19% | down 0.09 pts | ₹28.4 Cr | up ₹1.1 Cr | Added |
| Abiomed Inc | 2.80% | up 0.05 pts | ₹25 Cr | up ₹2 Cr | Added |
| Syngene International Limited | 2.79% | down 0.29 pts | ₹24.8 Cr | down ₹84 L | Trimmed |
| Abbott Laboratories | 2.76% | down 0.19 pts | ₹24.6 Cr | up ₹4 L | Held |
| Alkem Laboratories Limited | 2.58% | down 0.33 pts | ₹22.9 Cr | down ₹1.3 Cr | Trimmed |
| Narayana Hrudayalaya Limited | 2.53% | down 0.30 pts | ₹22.5 Cr | down ₹1.1 Cr | Trimmed |
| Jubilant Pharmova Limited | 2.52% | down 0.18 pts | ₹22.4 Cr | down ₹8 L | Held |
| Aarti Drugs Limited | 2.49% | down 0.53 pts | ₹22.2 Cr | down ₹2.9 Cr | Trimmed |
| Alembic Pharmaceuticals Limited | 2.41% | down 0.10 pts | ₹21.5 Cr | up ₹59 L | Added |
| Indoco Remedies Limited | 2.39% | down 0.16 pts | ₹21.3 Cr | up ₹5 L | Held |
| Unichem Laboratories Limited | 1.85% | down 0.08 pts | ₹16.5 Cr | up ₹41 L | Added |
| Abbott India Limited | 1.09% | down 0.17 pts | ₹9.7 Cr | down ₹75 L | Trimmed |
| Ajanta Pharma Limited | 0.96% | down 0.09 pts | ₹8.6 Cr | down ₹22 L | Trimmed |
What changed, Sep 2020 to Oct 2020
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- IPCA Laboratories Limitedup ₹20.8 Cr (+1.83% pts)
- Dr. Reddy's Laboratories Limitedup ₹6.2 Cr (+0.10% pts)
- Divi's Laboratories Limitedup ₹5.9 Cr (+0.30% pts)
- Dr. Lal Path Labs Limitedup ₹5.4 Cr (+0.42% pts)
- Cipla Limitedup ₹4.4 Cr (−0.12% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2020, the weight rose most in Pharmaceuticals & Biotechnology (+0.7 pts) and Healthcare Equipment & Supplies (+0.3 pts), and fell most in Insurance (−0.4 pts) and Pharmaceuticals (−0.3 pts).
- Pharmaceuticals & Biotechnology62.8% → 63.5%+0.7 pts
- Healthcare Equipment & Supplies3.5% → 3.8%+0.3 pts
- Insurance4.0% → 3.6%−0.4 pts
- Pharmaceuticals8.0% → 7.6%−0.3 pts
- Healthcare Services21.7% → 21.4%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2019 | Apr 2020 | Jul 2020 | Sep 2020 | Oct 2020 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 68.5% | 70.7% | 66.7% | 62.8% | 63.5% |
| Healthcare Services | 18.9% | 15.3% | 17.2% | 21.7% | 21.4% |
| Pharmaceuticals | 11.0% | 10.1% | 9.6% | 8.0% | 7.6% |
| Healthcare Equipment & Supplies | — | 1.6% | 3.0% | 3.5% | 3.8% |
| Insurance | 1.6% | 2.4% | 3.5% | 4.0% | 3.6% |
Allocation in Oct 2020change vs Sep 2020
- Pharmaceuticals & Biotechnology (13)63.5%▲ 0.7 pts
- Healthcare Services (6)21.4%▼ 0.3 pts
- Pharmaceuticals (3)7.6%▼ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Oct 2020
8.2%
▲ 1.6 pts vs Sep 2020
- Cash alone
- 8.2%
- cash and net receivables
- A year earlier
- 1.7%
- Oct 2019 · now ▲ 6.5 pts
- Last 12 months
- 2.0% – 8.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.